Langerhans cell histiocytosis (LCH) is a rare histiocytic neoplasm arising from clonal proliferation of dendritic Langerhans cells. The temporal bone is the most commonly affected skull bone, and temporal bone involvement has been reported in 15-61% of all LCH cases. The disease typically occurs in children aged 1-15 years and is 2:1 more common in males. Clinical presentation includes recurrent otitis media, treatment-resistant otorrhea, retroauricular swelling, and conductive hearing loss. Confusion with otitis media can delay diagnosis. Temporal bone involvement may be unifocal (eosinophilic granuloma) or part of multisystemic disease — prognosis and treatment are shaped accordingly. Unifocal disease has excellent prognosis (95% cure), while multisystemic disease has high mortality despite chemotherapy.
Age Range
1-15
Peak Age
5
Gender
Equal
Prevalence
Rare
In LCH, pathological Langerhans cells carry BRAF V600E mutation (50-60%) or MAP2K1 mutation — these mutations constitutively activate the RAS-RAF-MEK-ERK signaling pathway. Activated cells infiltrate bone marrow and initiate aggressive bone resorption together with osteoclast-like giant cells. Lytic lesions in the temporal bone form through osteoclastic activity via the RANKL/RANK/OPG signaling system — therefore lytic lesions are sharply marginated ('punched-out') and there is no reactive sclerosis in surrounding bone (osteoblastic response is suppressed). Absence of sclerotic rim is the most distinguishing CT feature — other lytic lesions such as metastasis and osteomyelitis typically show surrounding reactive sclerosis. The soft tissue component can extend from the bone defect to the subperiosteal space and external auditory canal — this extension is best evaluated on MRI. Loss of mastoid pneumatization results from the disease involving bone marrow and obliterating air cells.
Sharply marginated lytic lesion in the temporal bone — no sclerotic rim (reactive bone) surrounding it. This feature results from suppression of osteoblastic response in LCH and is nearly pathognomonic for the pathology. Other lytic lesions (metastasis, osteomyelitis) usually show surrounding reactive sclerosis.
Sharply marginated, 'punched-out' lytic bone lesion. No sclerotic rim is present — this feature is the most important CT finding distinguishing LCH from other lytic lesions. Lesion margins are as sharp as if cut with surgical instruments. Size is usually 1-4 cm.
Report Sentence
A sharply marginated lytic lesion measuring ___ x ___ mm in the temporal bone is identified without surrounding sclerotic rim; this appearance is consistent with Langerhans cell histiocytosis.
Mastoid bone destruction and loss of pneumatization. Mastoid air cells are obliterated by the lytic lesion. Lesion can extend to squamous temporal bone and petrous apex. Ossicular erosion may occur but inner ear structures are usually preserved.
Report Sentence
Loss of pneumatization and lytic bone destruction in the mastoid bone is observed; the lesion extends toward ___.
Hyperintense soft tissue component on T2-weighted images extends from bone defect to external auditory canal and retroauricular region. High T2 signal reflects the free water content of cellular LCH infiltrate. Dural involvement may also be seen as hyperintense on T2.
Report Sentence
Hyperintense soft tissue component on T2-weighted images extends through the bone defect to the external auditory canal; consistent with temporal bone LCH.
Prominent homogeneous enhancement on post-contrast T1-weighted images. Enhancement reflects the intense vascularity of LCH infiltrate. Dural extension is best evaluated on contrast-enhanced series.
Report Sentence
Prominent homogeneous enhancement of the lesion is observed on contrast-enhanced series; careful evaluation for dural extension is recommended.
Differential involvement of inner and outer tables creates 'beveled edge' appearance. The outer table is usually more destructed than the inner table — this asymmetric involvement causes the lesion margin to appear shelving on axial CT. This finding is a classic sign of calvarial LCH.
Report Sentence
Beveled edge appearance due to differential involvement of inner and outer tables is observed in the lytic lesion, consistent with calvarial LCH.
Variable diffusion restriction on DWI — mild-moderate restriction may be seen in cellular LCH lesions. Intense cellularity can cause diffusion restriction but this finding is not specific. ADC values are generally higher than abscess and high-grade tumors.
Report Sentence
Mild-moderate diffusion restriction is observed in the lesion on DWI (ADC: ___ x 10-3 mm2/s); consistent with LCH, abscess should be excluded.
Criteria
Single bone lesion, no systemic involvement. Most common form (60-80%). Usually in children >2 years.
Distinct Features
Excellent prognosis (95% cure). Curettage or steroid injection sufficient. Spontaneous regression may occur. Skeletal survey to exclude other lesions.
Criteria
Multiple bone lesions or multiple involvement within same organ system. No systemic symptoms.
Distinct Features
Chemotherapy usually required. Risk of diabetes insipidus development (10-15%). Temporal bone + mandible + orbit involvement common.
Criteria
Two or more organ system involvement (bone + skin + liver/spleen/hematopoietic). Poor prognosis with risk organ involvement.
Distinct Features
Systemic chemotherapy mandatory (vinblastine + prednisolone). Mortality 10-50% (depending on risk organ involvement). Letterer-Siwe disease is the severe form of this group.
Distinguishing Feature
Metastasis has more irregular margins and surrounding reactive sclerosis may be present; also older age and known primary malignancy history are distinguishing. LCH has sharp margins without sclerotic rim.
Distinguishing Feature
Osteomyelitis shows bone destruction with surrounding sclerosis and periosteal reaction; sequestrum formation may occur. LCH has no sclerotic rim and minimal or no periosteal reaction. Clinically, fever and leukocytosis are prominent in osteomyelitis.
Distinguishing Feature
Ewing sarcoma is characterized by permeative bone destruction, aggressive periosteal reaction (onion peel), and large soft tissue component. LCH has geographic (punched-out) destruction and minimal periosteal reaction. Age groups may overlap but lesion in Ewing is usually larger.
Distinguishing Feature
Fibrous dysplasia shows expansile ground-glass density bone lesion — LCH shows lytic destructive lesion. In fibrous dysplasia, bone expands but cortical integrity is preserved; in LCH, bone is destructed.
Urgency
urgentManagement
medicalBiopsy
NeededFollow-up
3-monthAlthough temporal bone LCH diagnosis is strongly suggested by CT and MRI findings, histopathological confirmation (biopsy) is required — CD1a and S-100 positivity confirms the diagnosis. Curettage + intralesional steroid is sufficient for unifocal lesion; chemotherapy (vinblastine + prednisolone) is needed for multifocal/multisystemic disease. Systemic screening (skeletal survey, liver/spleen assessment, diabetes insipidus screening) should be performed in all cases. Regular post-treatment follow-up (CT/MRI every 3-6 months) is important for recurrence.
LCH temporal bone involvement can lead to hearing loss and facial nerve paralysis if untreated. Investigation for systemic disease is necessary. Treatment includes local curettage, steroid injection, or systemic chemotherapy.